Gülbû Uzel

17.4k total citations
99 papers, 5.2k citations indexed

About

Gülbû Uzel is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, Gülbû Uzel has authored 99 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Immunology, 32 papers in Epidemiology and 25 papers in Genetics. Recurrent topics in Gülbû Uzel's work include Immunodeficiency and Autoimmune Disorders (56 papers), Immune Cell Function and Interaction (27 papers) and Blood disorders and treatments (17 papers). Gülbû Uzel is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (56 papers), Immune Cell Function and Interaction (27 papers) and Blood disorders and treatments (17 papers). Gülbû Uzel collaborates with scholars based in United States, Australia and United Kingdom. Gülbû Uzel's co-authors include Steven M. Holland, Helen C. Su, Helen Matthews, Jeremiah C. Davis, Michael J. Lenardo, Alexandra F. Freeman, Benjamin Chaigne-Delalande, Sergio D. Rosenzweig, Theo Heller and Beatriz E. Marciano and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Gülbû Uzel

98 papers receiving 5.1k citations

Peers

Gülbû Uzel

IMMUN

EPIDE

GENET

Sergio D. Rosenzweig United States

Kazunaga Agematsu Japan

Bernd H. Belohradsky Germany

Guy Gorochov France

Paul Schwarzenberger United States

S. Cindy Australia

Lauri Diehl United States

Thomas A. Fleisher United States

Klaus Warnatz Germany

László Maródi Hungary

Sergio D. Rosenzweig United States

Gülbû Uzel

2.9k ×0.9

IMMUN

1.0k ×1.0

EPIDE

843 ×0.8

GENET

709 ×0.9

918 ×1.3

Citations per year, relative to Gülbû Uzel Gülbû Uzel (= 1×) peers Sergio D. Rosenzweig

Countries citing papers authored by Gülbû Uzel

Since Specialization

Citations

This map shows the geographic impact of Gülbû Uzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gülbû Uzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gülbû Uzel more than expected).

Fields of papers citing papers by Gülbû Uzel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gülbû Uzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gülbû Uzel. The network helps show where Gülbû Uzel may publish in the future.

Co-authorship network of co-authors of Gülbû Uzel

This figure shows the co-authorship network connecting the top 25 collaborators of Gülbû Uzel. A scholar is included among the top collaborators of Gülbû Uzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gülbû Uzel. Gülbû Uzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shapiro, Adam J., Eveline Y. Wu, Déborah Morris-Rosendahl, et al.. (2025). Overlapping Clinical Phenotypes in Patients with Primary Ciliary Dyskinesia or Activated Phosphoinositide 3-Kinase Delta Syndrome. The Journal of Pediatrics. 280. 114499–114499. 1 indexed citations

Hercun, Julian, Anusha Vittal, Jenna Bergerson, et al.. (2024). Development of hepatic fibrosis in common variable immunodeficiency‐related porto‐sinusoidal vascular disorder. Alimentary Pharmacology & Therapeutics. 60(7). 888–896. 1 indexed citations

Ochoa, Sebastian, Michael S. Abers, Lindsey B. Rosen, et al.. (2023). Management and outcome of COVID-19 in CTLA-4 insufficiency. Blood Advances. 7(19). 5743–5751. 3 indexed citations

Santos, Cristiane N., Christopher Koh, Keith Sacco, et al.. (2021). Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication. Journal of Allergy and Clinical Immunology. 149(1). 400–409.e3. 11 indexed citations

Schindler, Matthew K., Stefania Pittaluga, Yoshimi Enose‐Akahata, et al.. (2020). Haploinsufficiency of immune checkpoint receptor CTLA4 induces a distinct neuroinflammatory disorder. Journal of Clinical Investigation. 130(10). 5551–5561. 18 indexed citations

Myles, Ian A., Noah Earland, Erik D. Anderson, et al.. (2018). First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis. JCI Insight. 3(9). 234 indexed citations

Ruiz‐García, Raquel, Alexander Vargas‐Hernández, Iván K. Chinn, et al.. (2018). Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatment. Journal of Allergy and Clinical Immunology. 142(2). 605–617.e7. 36 indexed citations

Schickel, Jean‐Nicolas, Salomé Glauzy, Yen-Shing Ng, et al.. (2017). Self-reactive VH4-34–expressing IgG B cells recognize commensal bacteria. The Journal of Experimental Medicine. 214(7). 1991–2003. 58 indexed citations

Fritz, Jill M., Alejandro V. Villarino, Lixin Zheng, et al.. (2017). STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells. The Journal of Immunology. 200(1). 110–118. 27 indexed citations

10.

Moraes‐Fontes, Maria Francisca, Amy P. Hsu, Íris Caramalho, et al.. (2017). Fatal CTLA ‐4 heterozygosity with autoimmunity and recurrent infections: a de novo mutation. Clinical Case Reports. 5(12). 2066–2070. 4 indexed citations

11.

Moutsopoulos, Niki M., Christa S. Zerbe, Teresa Wild, et al.. (2017). Interleukin-12 and Interleukin-23 Blockade in Leukocyte Adhesion Deficiency Type 1. New England Journal of Medicine. 376(12). 1141–1146. 110 indexed citations

12.

Fan, Xiying, Bhaskar Upadhyaya, Liming Wu, et al.. (2012). CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome. Clinical Immunology. 143(2). 152–161. 16 indexed citations

13.

Vinh, Donald C., B. Schwartz, Amy P. Hsu, et al.. (2011). Interleukin-12 Receptor 1 Deficiency Predisposing to Disseminated Coccidioidomycosis. Clinical Infectious Diseases. 52(4). e99–e102. 70 indexed citations

14.

Kuhns, Douglas B., W. Gregory Alvord, Theo Heller, et al.. (2010). Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease. New England Journal of Medicine. 363(27). 2600–2610. 354 indexed citations

15.

Gottlieb, Chloe, Zhuqing Li, Gülbû Uzel, Robert B. Nussenblatt, & H. Nida Sen. (2010). Uveitis in DiGeorge syndrome: a case of autoimmune ocular inflammation in a patient with deletion 22q11.2. Ophthalmic Genetics. 31(1). 24–29. 8 indexed citations

16.

Murray, Patrick R., Gülbû Uzel, Raymond Ranken, et al.. (2010). Pyoderma Gangrenosum–Like Ulcer in a Patient With X-Linked Agammaglobulinemia. Archives of Dermatology. 146(5). 523–6. 19 indexed citations

17.

Tran, Dat Q., Deborah D. Glass, Gülbû Uzel, et al.. (2009). Analysis of Adhesion Molecules, Target Cells, and Role of IL-2 in Human FOXP3+ Regulatory T Cell Suppressor Function. The Journal of Immunology. 182(5). 2929–2938. 85 indexed citations

18.

Zhang, Qian, Jeremiah C. Davis, Ian T. Lamborn, et al.. (2009). Combined Immunodeficiency Associated with DOCK8 Mutations. New England Journal of Medicine. 361(21). 2046–2055. 482 indexed citations

19.

Uzel, Gülbû & Steven M. Holland. (2000). Th1 T-CELL AND MONOCYTE DEFECTS. Pediatric Clinics of North America. 47(6). 1275–1289. 4 indexed citations

20.

Dorman, Susan E., Gülbû Uzel, Joachim Roesler, et al.. (1999). Viral infections in interferon-γ receptor deficiency. The Journal of Pediatrics. 135(5). 640–643. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact